tonix.co.nz
Provided by Alexa ranking, tonix.co.nz has ranked N/A in N/A and N/A on the world. It is hoted in N/A with IP address 137.184.180.166. The home page has 0 external link.
Category: Tonix Health Recruitment New Zealand
Top keyword related from Search Engine of tonix.co.nz
Traffic Ranks of tonix.co.nz
| Owner: |
N/A |
| RANK: |
N/A |
| Country code: |
N/A |
| Country name: |
N/A |
| Rank on country: |
N/A |
| Host: |
N/A |
| Ip: |
137.184.180.166 |
| Ref link: |
|
| Extension: |
co.nz |
Top URL related to tonix.co.nz
-
1. Home - Tonix Pharmaceuticals
Link: https://www.tonixpharma.com/
Description: WEBMar 21, 2024 · Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases.
-
2. Tonix Pharmaceuticals Holding Corp. (TNXP) - Yahoo Finance
Link: https://finance.yahoo.com/quote/TNXP
Description: WEBFind the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock quote, history, news and other vital information to help you with your stock trading and investing.
-
3. Tonix Pharmaceuticals Announces Transition to Fully Integrated
Link: https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-transition-fully-120000300.html
Description: WEBMar 19, 2024 · Commercial capabilities prepare Tonix for the potential launch in 2025 of Tonmya™ for the management of fibromyalgia, assuming FDA approval
-
4. Tonix Pharmaceuticals - Wikipedia
Link: https://en.m.wikipedia.org/wiki/Tonix_Pharmaceuticals
Description: WEBTonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
-
5. The Next Drug for Fibromyalgia? Tonix's Tomnya Sleep AND …
Link: https://www.healthrising.org/blog/2024/04/15/tonix-tomnya-fibromyalgia-sleep-pain/
Description: WEB4 days ago · Tonix reported that this time the drug met its pre-specified primary endpoint by significantly reducing daily pain compared to placebo (p=0.00005). Tonix reported that clinically meaningful results were also seen in all major secondary endpoints related to improving sleep quality, reducing fatigue, and improving overall fibromyalgia symptoms ...
-
6. Press Releases :: Tonix Pharmaceuticals Holding Corp. (TNXP)
Link: https://ir.tonixpharma.com/news-events/press-releases
Description: WEBMar 25, 2024 · Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights Mar 28, 2024 9:32am EDT Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
-
7. Tonix Pharmaceuticals Announces Registered Direct Offering of …
Link: https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-registered-direct-153500432.html
Description: WEBCHATHAM, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates ...
-
8. Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price & News …
Link: https://www.google.com/finance/quote/TNXP:NASDAQ
Description: WEBUnited States. Website. tonixpharma.com. Employees. 103. Get the latest Tonix Pharmaceuticals Holding Corp (TNXP) real-time quote, historical performance, charts, and other financial information ...
-
9. Tonix Pharmaceuticals Announces Positive Results from Clinical
Link: https://ir.tonixpharma.com/news-events/press-releases/detail/1454/tonix-pharmaceuticals-announces-positive-results-from
Description: WEBFeb 27, 2024 · New Drug Application (NDA) submission to the U.S. FDA for the approval of Tonmya for the management of fibromyalgia planned for second half of 2024. CHATHAM, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of ...
-
10. Tonix Pharmaceuticals Announces FDA Clearance of the IND
Link: https://www.globenewswire.com/news-release/2021/11/23/2339689/28908/en/Tonix-Pharmaceuticals-Announces-FDA-Clearance-of-the-IND-for-Potentiated-Intranasal-Oxytocin-TNX-1900-for-the-Prevention-of-Migraine-Headache-in-Chronic-Migraineurs.html
Description: WEBNov 23, 2021 · Tonix Pharmaceuticals Announces FDA Clearance of the IND for Potentiated Intranasal Oxytocin (TNX-1900) for the Prevention of Migraine Headache in Chronic Migraineurs. November 23, 2021 07:00 ET...
